← MetLife overview
MetLife IncMET

Why is MetLife (MET) moving?

Q3 2026
▲3▼1

MetLife Q2 Earnings Beat, Buyback, Upgrade; Private-Credit Short Bets Loom

  • Strong Q2 earnings and buyback MetLife's second-quarter adjusted earnings jumped 15% to $1.6 billion, with every business segment growing and return on equity hitting its target. A new $3 billion stock buyback also supports the share price.

    This is the core positive fundamental news that drove the stock during the period.

  • Record annuity sales and higher rates Record annuity sales boosted retirement earnings, and higher-for-longer interest rates lifted investment income. Piper Sandler upgraded MetLife to Overweight with a $110 price target, citing these strengths.

    These are new positive operational and analyst-driven catalysts for the period.

  • New CLO adds fee income MetLife's investment arm closed a $450 million collateralized loan obligation (CLO), which pools loans and sells slices to investors. This adds fee income and shows the company's ability to generate revenue beyond insurance.

    This is a new business development that contributed to positive sentiment.

  • Private-credit short bets and revenue miss Short sellers Lee Robinson and Michael Burry are betting against MetLife over its private-credit exposure, warning of potential losses even though no problems have been reported. Meanwhile, Q2 revenue rose 6.4% but missed estimates, adding to pressure.

    This is the main negative force weighing on sentiment during the period.

August 2026
▲3▼1

MetLife Q2 Earnings Beat, Buyback, Upgrade; Private-Credit Short Bets Loom

  • Strong Q2 earnings and buyback MetLife's second-quarter adjusted earnings jumped 15% to $1.6 billion, with every business segment growing and return on equity hitting its target. A new $3 billion stock buyback also supports the share price.

    This is the core positive fundamental news that drove the stock during the period.

  • Record annuity sales and higher rates Record annuity sales boosted retirement earnings, and higher-for-longer interest rates lifted investment income. Piper Sandler upgraded MetLife to Overweight with a $110 price target, citing these strengths.

    These are new positive operational and analyst-driven catalysts for the period.

  • New CLO adds fee income MetLife's investment arm closed a $450 million collateralized loan obligation (CLO), which pools loans and sells slices to investors. This adds fee income and shows the company's ability to generate revenue beyond insurance.

    This is a new business development that contributed to positive sentiment.

  • Private-credit short bets and revenue miss Short sellers Lee Robinson and Michael Burry are betting against MetLife over its private-credit exposure, warning of potential losses even though no problems have been reported. Meanwhile, Q2 revenue rose 6.4% but missed estimates, adding to pressure.

    This is the main negative force weighing on sentiment during the period.

Latest
▲3▼1

Burry's private-credit short weighs on MetLife, but core profit and analyst upgrade support

  • Burry escalates bearish MetLife bet on private-credit fears Michael Burry added long-dated put options on MetLife, warning insurers hold too many bad assets as private credit and private equity show strain. This scares investors and can push MET shares down, even though MetLife has not reported actual losses.

    This is the main new negative force on MET this period, directly linking Burry's short to private-credit worries.

  • Piper Sandler upgrades MetLife to Overweight, $110 target Piper Sandler upgraded MetLife to Overweight from Neutral and raised its price target to $110 from $99, citing the company's strengths. Analyst upgrades often draw new buyers and can lift the stock price.

    A fresh analyst upgrade is a new positive catalyst that can directly support MET's price.

  • MetLife's investment arm closes $450 million CLO MetLife Investment Management closed Galaxy 38, a $450 million collateralized loan obligation, expanding its fee-generating CLO platform. More fee income from managing these funds supports profits and helps the stock.

    This new deal shows MetLife growing a fee-based business, a positive driver for earnings and the stock.

  • Q2 revenue rises 6.4% but misses estimates MetLife's second-quarter revenue rose 6.4% to $19.08 billion but fell 2.2% short of analyst estimates, part of a mixed quarter for life insurers. The miss may disappoint some investors, but the stock held steady as growth remained solid.

    This is the period's key earnings update, showing growth but a miss that tempers the positive picture.

▲3▼1

MetLife's core profit engine is strong, but private-credit bets draw short sellers

  • Short seller targets MetLife over private credit Hedge fund manager Lee Robinson is betting against MetLife and other insurers, warning that their growing private-credit holdings could lead to losses. This scares some investors and can push MET shares down, even though MetLife has not reported actual problems.

    This is a new risk that directly targets MetLife and could weigh on the stock.

  • Higher-for-longer rates boost investment income The Fed is holding rates high, which lets MetLife earn more on its huge bond portfolio. That supports profits and helps the stock, as long as rates don't spike so fast that they hurt the broader economy.

    This is a key force behind MetLife's earnings growth and stock performance.

  • Strong Q2 earnings and new $3B buyback MetLife's second-quarter adjusted earnings rose 15% to $1.6 billion, with every segment growing. Return on equity hit the top of its target, and the company authorized a new $3 billion share buyback, which supports the stock price.

    This is the main positive news of the period and directly lifts investor confidence.

  • Record annuity sales lift retirement business US annuity sales hit a record $228.7 billion in the first half, and MetLife's retirement segment earned $377 million. More people buying annuities means more revenue and profit for MetLife, which helps the stock.

    This shows strong demand for MetLife's products and supports future earnings.